Cargando…

Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice

Galectin-3 is a carbohydrate-binding lectin, which has been implicated in the modulation of atherosclerotic pathophysiology, and is highly expressed in monocytes, macrophages and endothelial cells within atherosclerotic plaques. Modified citrus pectin (MCP) is produced from citrus pectin via pH and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yonggang, Zhang, Mingming, Zhao, Pei, Jia, Min, Liu, Bing, Jia, Qian, Guo, Jun, Dou, Lin, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482107/ https://www.ncbi.nlm.nih.gov/pubmed/28560429 http://dx.doi.org/10.3892/mmr.2017.6646

Ejemplares similares

Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
por: Lau, Emily S., et al.
Publicado: (2021)

Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
por: Kolatsi-Joannou, Maria, et al.
Publicado: (2011)

Purification, chemical analysis and inhibitory effects on galectin-3 of enzymatic pH-modified citrus pectin
por: Zhang, Tao, et al.
Publicado: (2021)

Pleiotropic Effects of Modified Citrus Pectin
por: Eliaz, Isaac, et al.
Publicado: (2019)

PAC1 deficiency reduces chondrogenesis in atherosclerotic lesions of hypercholesterolemic ApoE-deficient mice
por: Blümm, C., et al.
Publicado: (2023)

Induction of Heme Oxygenase-1 Modifies the Systemic Immunity and Reduces Atherosclerotic Lesion Development in ApoE Deficient Mice
por: Yao, Leyi, et al.
Publicado: (2022)

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model
por: Jia, Chenglin, et al.
Publicado: (2014)

Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer
por: Conti, Sefora, et al.
Publicado: (2018)

Citrus pectin modified by microfluidization and ultrasonication: Improved emulsifying and encapsulation properties
por: Wang, Wenjun, et al.
Publicado: (2020)

Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids
por: Hossein, Ghamartaj, et al.
Publicado: (2019)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Darbepoetin Alpha Reduces Oxidative Stress and Chronic Inflammation in Atherosclerotic Lesions of Apo E Deficient Mice in Experimental Renal Failure
por: Arend, Nicole, et al.
Publicado: (2014)

Synergistic Antioxidant and Anti-Inflammatory Effects between Modified Citrus Pectin and Honokiol
por: Ramachandran, Cheppail, et al.
Publicado: (2017)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(−/−) Mice
por: Horie, Takahiro, et al.
Publicado: (2012)

AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(−/−) mice
por: Burgmaier, Mathias, et al.
Publicado: (2014)

Evaluation of the prebiotic effects of citrus pectin hydrolysate
por: Ho, Yen-Yi, et al.
Publicado: (2017)

Overexpression of TGF-ß1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice
por: Reifenberg, Kurt, et al.
Publicado: (2012)

Microencapsulation of Tangeretin in a Citrus Pectin Mixture Matrix
por: Sun, Xiuxiu, et al.
Publicado: (2020)

Chemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells
por: Wang, Shi, et al.
Publicado: (2016)

Doxycycline Decreases Atherosclerotic Lesions in the Aorta of ApoE(-⁄-) and Ovariectomized Mice with Correlation to Reduced MMP-2 Activity
por: Rodrigues, Keuri E., et al.
Publicado: (2022)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

Physicochemical and functional properties of Cucurbita maxima pumpkin pectin and commercial citrus and apple pectins: A comparative evaluation
por: Torkova, Anna A., et al.
Publicado: (2018)

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass
por: Jacobi, Johannes, et al.
Publicado: (2014)

Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
por: Zhou, Qianxing, et al.
Publicado: (2011)

Crude α-Mangostin Suppresses the Development of Atherosclerotic Lesions in Apoe-Deficient Mice by a Possible M2 Macrophage-Mediated Mechanism
por: Shibata, Masa-Aki, et al.
Publicado: (2019)

Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
por: Stegmayr, John, et al.
Publicado: (2016)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021)

Controlling the Degree of Esterification of Citrus Pectin for Demanding Applications by Selection of the Source
por: Ciriminna, Rosaria, et al.
Publicado: (2017)

Systematic Analysis and Functional Validation of Citrus Pectin Acetylesterases (CsPAEs) Reveals that CsPAE2 Negatively Regulates Citrus Bacterial Canker Development
por: Li, Qiang, et al.
Publicado: (2020)

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice
por: Okamoto, Ryoko, et al.
Publicado: (2014)

Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice
por: Wang, Xiaogang, et al.
Publicado: (2011)

Metabolic disturbances and worsening of atherosclerotic lesions in ApoE(-/-) mice after cola beverages drinking
por: Otero-Losada, Matilde E, et al.
Publicado: (2013)

Cardiovascular Changes in Atherosclerotic ApoE-Deficient Mice Exposed to Co60 (γ) Radiation
por: Kumarathasan, Prem, et al.
Publicado: (2013)

Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage Polarity
por: Kane, Jamie, et al.
Publicado: (2022)

The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?
por: Pedrosa, Lucas de Freitas, et al.
Publicado: (2022)

bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice
por: Parma, Laura, et al.
Publicado: (2020)

Pectin from Citrus Canning Wastewater as Potential Fat Replacer in Ice Cream
por: Zhang, Hua, et al.
Publicado: (2018)

Physicochemical and sensory quality of yogurt incorporated with pectin from peel of Citrus sinensis
por: Arioui, Fatiha, et al.
Publicado: (2016)

Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
por: Subudhi, M. Biswaranjan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g6qd1ugjnus1la7kdsolu4ffd3